Monteleone, G., Di Sabatino, A., Ardizzone, S., Pallone, F., Usiskin, K., Zhan, X., . . . Neurath, M. F. (2016). Impact of patient characteristics on the clinical efficacy of mongersen (GED‐0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease. Aliment Pharmacol Ther.
Citación estilo ChicagoMonteleone, G., A. Di Sabatino, S. Ardizzone, F. Pallone, K. Usiskin, X. Zhan, G. Rossiter, and M. F. Neurath. "Impact of Patient Characteristics On the Clinical Efficacy of Mongersen (GED‐0301), an Oral Smad7 Antisense Oligonucleotide, in Active Crohn's Disease." Aliment Pharmacol Ther 2016.
Cita MLAMonteleone, G., et al. "Impact of Patient Characteristics On the Clinical Efficacy of Mongersen (GED‐0301), an Oral Smad7 Antisense Oligonucleotide, in Active Crohn's Disease." Aliment Pharmacol Ther 2016.